Dr. Michael Große

Dr. Michael Große, listed as senior executive, appears in our data through filings on Sartorius Aktiengesellschaft shares, published by BaFin. In total, 3 filings cover trades dated 2 July 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 7 July 2025, reports a transaction in Sartorius Aktiengesellschaft. Between a trade and the moment it shows up on BaFin, the median delay is 5 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from BaFin. Past trades are no guide to future returns.